In animal and human studies, pure GIP protocols model glucose spikes and fat accumulation
In a nationally representative survey of 2,001 adults on commercial insurance, the Employee Benefit Research Institute (EBRI) found that about 18% had taken GLP-1 medications and 35% of those had stopped
Testing is $298
Preventive Care : Think annual check-ups, screenings, and shots
Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB
Discussion This study demonstrates that newer anti-obesity medications, particularly Tirzepatide and Semaglutide, show superior ocular safety profiles relative to traditional agents like Phentermine/Topiramate, Naltrexone/Bupropion, and Phentermine in people with obesity